CoChat

Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1 R,2 S,3 R)-1,2,3,4-Tetrahydroxybutyl)-1 H-imidazol-2-yl)ethanone Oxime (LX2931) and (1 R,2 S,3 R)-1-(2-(Isoxazol-3-yl)-1 H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)

Bagdanoff, Jeffrey T., Donoviel, Michael S., Nouraldeen, Amr, Carlsen, Marianne, Jessop, Theodore C., Tarver, James, Aleem, Saadat, Dong, Li, Zhang, Haiming, Boteju, Lakmal, Hazelwood, Jill, Yan, Jack, Bednarz, Mark, Layek, Suman, Owusu, Iris B., Gopinathan, Suma, Moran, Liam, Lai, Zhong, Kramer, Jeff, Kimball, S. David, Yalamanchili, Padmaja, Heydorn, William E., Frazier, Kenny S., Brooks, Barbara, Brown, Philip, Wilson, Alan, Sonnenburg, William K., Main, Alan, Carson, Kenneth G., Oravecz, Tamas, Augeri, David J. · 2010 · Journal of Medicinal Chemistry
Cited by 113

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Sphingosine 1-phosphate lyase (S1PL) has been characterized as a novel target for the treatment of autoimmune disorders using genetic and pharmacological methods. Medicinal chemistry efforts targeting S1PL by direct in vivo evaluation of synthetic analogues of 2-acetyl-4(5)-(1(R),2(S),3(R),4-tetrahydroxybutyl)-imidazole (THI, 1) led to the discovery of 2 (LX2931) and 4 (LX2932). The immunological phenotypes observed in S1PL deficient mice were recapitulated by oral administration of 2 or 4. Oral dosing of 2 or 4 yielded a dose-dependent decrease in circulating lymphocyte numbers in multiple species and showed a therapeutic effect in rodent models of rheumatoid arthritis (RA). Phase I clinical trials indicated that 2, the first clinically studied inhibitor of S1PL, produced a dose-dependent and reversible reduction of circulating lymphocytes and was well tolerated at dose levels of up to 180 mg daily. Phase II evaluation of 2 in patients with active rheumatoid arthritis is currently underway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jm101183p

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Bagdanoff, J. T., Donoviel, M. S., Nouraldeen, A., Carlsen, M., Jessop, T. C., Tarver, J., Aleem, S., Dong, L., Zhang, H., Boteju, L., Hazelwood, J., Yan, J., Bednarz, M., Layek, S., Owusu, I. B., Gopinathan, S., Moran, L., Lai, Z., Kramer, J., Kimball, S. D., Yalamanchili, P., Heydorn, W. E., Frazier, K. S., Brooks, B., Brown, P., Wilson, A., Sonnenburg, W. K., Main, A., Carson, K. G., Oravecz, T., & Augeri, D. J.
Venue
Journal of Medicinal Chemistry
Published
2010-11-22
Volume
53
Issue
24
Pages
8650-8662
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W52199435
Cited by
113
References
2
FWCI
4.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.